Form4insider filings, from the source

SEC Form 4 · accession 0001093557-18-000205

DEXCOM INC · DXCM

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Andrew K Balo
Officer — EVP, Reg. Strategy, Clinical
Period of report
Sep 14, 2018
Accepted (ET)
Sep 18, 2018 · 7:54 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001093557

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2,F3Sep 14, 2018S600$144.4618D92,505D
Common StockF1,F4,F3Sep 14, 2018S4,400$145.2669D88,105D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses